Webinars & Presentations Webinar: Overview of a Flexible, Clinically Adaptable, Non-viral Approaches to CAR TCR Methodologies

Webinar: Overview of a Flexible, Clinically Adaptable, Non-viral Approaches to CAR TCR Methodologies

Abstract:
In this webinar for scientists and researchers, Rama Shivakumar, a senior scientist at MaxCyte Inc., highlights powerful case studies that demonstrate the successful use of MaxCyte’s clinically validated, scalable electroporation system in the pre-clinical and clinical scale engineering of resting and activated T cells using a mesothelin specific CARmRNA; in the enhancement of NK cell cytotoxicities against B cell malignancies using an antiCD19 CAR mRNA; in the transposon (Piggybac and Sleeping Beauty) based gene delivery for manufacture of CAR-T cells ; and finally in the gene editing of T cells for improving the efficacy of a TCR immunotherapy.

Watch Presentation

Cover slide of Overview of a Flexible, Clinically Adaptable, Non-viral Approaches to CAR TCR Methodologies

Presenter

MaxCyte_Thumbnail_Rama-Shivakumar@2x

Rama Shivakumar

Senior Scientist, Maxcyte, Inc.

Popular resources

Conditional-Deletion-of-Large-DNA-Fragment-in-iPSCs-by-ssODN-Mediated-Insertion-of-LoxP-Sites-without-Antibiotic-Selection-b 1
Scientific Brief
Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection
Conditional-Deletion-of-Large-DNA-Fragment-in-iPSCs-by-ssODN-Mediated-Insertion-of-LoxP-Sites-without-Antibiotic-Selection-Fig-2 1
Scientific Brief
Gene Editing: Paving the Way for Accelerated Clinical Development of Adoptive Cell Therapies
Experimental-Design-hires 1
Scientific Brief
Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection
View All Resources